VERO Stock Overview
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Venus Concept Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.72 |
52 Week High | US$4.70 |
52 Week Low | US$0.60 |
Beta | 0.60 |
1 Month Change | -23.73% |
3 Month Change | -40.00% |
1 Year Change | -79.22% |
3 Year Change | -97.96% |
5 Year Change | n/a |
Change since IPO | -99.08% |
Recent News & Updates
Recent updates
Shareholder Returns
VERO | US Medical Equipment | US Market | |
---|---|---|---|
7D | 12.2% | -0.2% | 0.6% |
1Y | -79.2% | 12.0% | 29.5% |
Return vs Industry: VERO underperformed the US Medical Equipment industry which returned 12% over the past year.
Return vs Market: VERO underperformed the US Market which returned 29.5% over the past year.
Price Volatility
VERO volatility | |
---|---|
VERO Average Weekly Movement | 23.6% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VERO's share price has been volatile over the past 3 months.
Volatility Over Time: VERO's weekly volatility has increased from 17% to 24% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 384 | Rajiv Kanishka De Silva | https://www.venusconcept.com |
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system.
Venus Concept Inc. Fundamentals Summary
VERO fundamental statistics | |
---|---|
Market cap | US$4.58m |
Earnings (TTM) | -US$36.05m |
Revenue (TTM) | US$82.51m |
0.1x
P/S Ratio-0.1x
P/E RatioIs VERO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VERO income statement (TTM) | |
---|---|
Revenue | US$82.51m |
Cost of Revenue | US$26.62m |
Gross Profit | US$55.89m |
Other Expenses | US$91.94m |
Earnings | -US$36.05m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 01, 2024
Earnings per share (EPS) | -5.67 |
Gross Margin | 67.74% |
Net Profit Margin | -43.69% |
Debt/Equity Ratio | -694.8% |
How did VERO perform over the long term?
See historical performance and comparison